ESTRO Guide 2019

Multidisciplinary Management of Prostate Cancer 19-23 May 2019 | Pisa, Italy

This interactive, multi- disciplinary and state- of-the art course on prostate cancer provides

in-depth knowledge of the disease and its

TARGET GROUP The course is aimed at radiation oncologists, urologists, medical oncologists and other specialists and trainees who have a special interest in prostate cancer and are willing to update their knowledge. COURSE AIM This 5-day teaching course aims at focusing on the management of localised, locally advanced and metastatic prostate cancer. It emphasises the importance of a multidisciplinary approach and teamwork, where full information exchange is vital to provide the best up-to-date scientific evidence on which the management of the disease will be based.This will be illustrated during state-of-the-art lectures presented by experts in the field, covering important issues such as biology, imaging, pathology, therapy and future developments. Interactive case studies and journal clubs will be integrated on a daily basis and there will be ample time for open discussions amongst participants and experts. A special session on target delineation for radiation oncologists will also be organised during the course. management, as well as an overview of the latest imaging and treatment techniques and drugs.

LEARNINGOUTCOMES • To provide an in-depth overview of the epidemiology, pathology, imaging and treatment options for low, intermediate and high risk prostate cancer • To discuss patient selection/indications and contra-indications for the various treatment options • To provide a critical overview of the surgical and radiotherapy techniques available for the management of prostate cancer • To discuss the new drugs currently available for the management of the advanced and metastatic stages of the disease • To debate on themost recent developments relevant to prostate cancer management.

COURSE CONTENT • Normal prostate: anatomy – embryology, histology • Prostate cancer: epidemiology and prevention, clinical diagnosis, imaging modalities pathology, staging • Low risk prostate cancer: active surveillance, surgery and the post-op pathology • Radiotherapy and brachytherapy, the pathology after irradiation • External beam radiotherapy: online control, target delineation • High risk prostate cancer: radiotherapy and hormones, alternative radiotherapy regimens • Toxicity of radiotherapy: acute and late morbidity – erectile dysfunction

52

SCHOOL